Minimal Residual Disease in Mouse Hepatocellular carcinoma [in vivo]
Transgenic MYC/Twist1 HCC uncergoes tumor regression with persistence of minimal residaul disease (MRD) in the liver upon oncogene deprivation. Overall design: Microdissected area of residual tumor in mouse HCC subjected to single nuclear RNA sequencing